Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease

Collapse authors list.
Lloyd, Katie, Papoutsopoulou, Stamatia ORCID: 0000-0001-6665-8508, Smith, Emily, Stegmaier, Philip, Bergey, Francois, Morris, Lorna, Kittner, Madeleine, England, Hazel, Spiller, Dave, White, Mike HR et al (show 10 more authors) , Duckworth, Carrie A ORCID: 0000-0001-9992-7540, Campbell, Barry J ORCID: 0000-0002-7407-012X, Poroikov, Vladimir, dos Santos, Vitor AP Martins, Kel, Alexander, Muller, Werner, Pritchard, D Mark ORCID: 0000-0001-7971-3561, Probert, Chris ORCID: 0000-0003-4550-0239, Burkitt, Michael D ORCID: 0000-0002-5055-6408 and Consortium, SysmeDIBD (2020) Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease. DISEASE MODELS & MECHANISMS, 13 (11).

Text Lloyd DMM.pdf - Author Accepted Manuscript Download (3MB) | Preview

Item Type:	Article
Uncontrolled Keywords:	Inflammatory bowel diseases, NF-kappa B, Drug repositioning, Interdisciplinary research, Organoids, Macrolide, Ulcerative colitis, Crohn's disease
Depositing User:	Symplectic Admin
Date Deposited:	28 Sep 2020 08:08
Last Modified:	18 Jan 2023 23:31
DOI:	10.1242/dmm.044040
Related URLs:	Author
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3102537

Available Versions of this Item

• Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease. (deposited 28 Sep 2020 08:08) [Currently Displayed]
  • Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease. (deposited 08 Nov 2021 14:26)